Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia.

Front Immunol · 2026 · PMC13318783 · PMID 42389523

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline significancep=0.051so close (0.05 < p ≤ 0.1)

However, the risk of GVHD correlates with the infused cell dose; patients receiving dose-escalation regimens show a trend toward reduced incidence of moderate-to-severe chronic GVHD (borderline significance, p=0.051) ( 18 ).

also in 4,327 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.